References
- Berdel W. E. Membrane-interactive lipids as experimental anticancer agents. Br. J. Cancer 1991; 64: 208
- Eibl H., Hilgard P., Unger C. Alkylphosphocholines: New drugs in cancer chemotherapy. Progress in experimental tumor research. Karger, Basel 1992; Vol. 34
- Grunicke H., Hofmann J. Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level. Pharmac. Ther. 1992; 55: 1
- Inoue K., Kitagawa T. Effect of exogenous lysolecithin on liposomal membranes its relation to membrane fluidity. Biochim Biophys Acta 1974; 363: 361
- Brachwitz H., Langen P., Arndt D., Fichtner I. Cytostatic activity of synthetic alkylglycerolipids. Lipids 1987; 22: 897
- Zeisig R., Jungmann S., Arndt D., Schütt A., Nissen E. Antineoplastic activity of free and liposomal alkylphosphocholines. Anti-Cancer Drugs 1993; 4: 57
- Zeisig R., Fichtner I., Arndt D., Jungmann S. Antitumor effect of alkylphosphocholines in different tumor modells; use of liposomal preparations. Anti-Cancer Drugs 1991; 2: 411
- Schumann R. R., Herrmann F. The macrophage: a tissue-specific defence cell — origin, diversity and function. Focus on Growth Factors 1994; 5: 1
- Fidler I. J. Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis. Res. Immunol. 1992; 143: 199
- Zeisig R., Jungmann S., Fichtner I., Deamen T., Arndt D. Cytotoxic effects of alkylphosphocholines or alkylphosphocholin-liposomes and macrophages on tumor cells. Anticancer Res. 1994, in press
- Roerdink F., Dijkstra J., Hartman G., Bolscher B., Scherphof G. The involvement of parenchymal, kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes: effects of lanthanum and gadolinium salts. Biochim Biophys Acta 1981; 677: 79
- Daemen T., Veninga A., Roerdink F., Scherphof G. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Cancer Res. 1986; 46: 4330
- Stuehr D. J., Nathan C. F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 1989; 169: 1543
- Green S. J., Mellouk Hoffmann S.L., Meitzer M. S., Nacy C. A. Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogenoxides from L-arginine by macrophages and hepatocytes. Immunol Letters 1990; 25: 15
- Singh R. K., Fidler I. J. Synergism between human recombinant monocyte chemotactic and activating factor and lipopolysaccharide for activation of antitumor properties in human blood monocytes. Lymphokine Cytokine Res. 1993; 12: 285
- Zeisig R., Rudolph M., Eue I., Arndt D. Influence of hexadecylphosphocholine on the release of tumor necrosis factor and nitroxide from peritoneal macrophages in vivo. J Cancer Res. Clinic. Oncology 1995, submitted for publication
- Eue I., Zeisig R., Arndt D. Alkylphosphocholine induced production of nitric oxide by J 774.A1 and U 937 macrophages. Biochem. Biopys. Res. Commun. 1995, submitted for publication
- Van Rooijen N. The liposome-mediated macrophage “suicide” technique. J. Immunol. Methods 1989; 124: 1
- Allen T. M. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Advanced Drug Delivery Reviews 1994; 13: 285
- Arndt D., Zeisig R., Eue I., Sternberg B., Fichtner I. Sterically stabilized hexadecyl-phosphocholine liposomes. Cancer Res. 1994, in reparation
- Wu N., Da D., Rudoll T, Needham D., Whorton R., Dewhurst M. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res. 1993; 53: 3765
- Allen T. M., Mehra T., Hansen Ch., Cheen Y. Stealth liposomes: an improved sustained release system for 1-ß-D-arabinofuranosylcytosine. Cancer Res. 1992; 52: 2431
- Vaage J., Donovan D., Mayhew E., Uster P., Woodle M. Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulted in sterically stabilized liposomes. Int. J. Cancer 1994; 54: 959